[ASAP] Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes

Journal of Proteome ResearchDOI: 10.1021/acs.jproteome.8b00118

Source: Journal of Proteome Research - July 17, 2018 Category: Biochemistry Authors: Ryan Lillico, Courtney K. Lawrence, Ted M. Lakowski Source Type: research